Merck Grants Sinopharm Rights to Covid Pills
US drugs giant Merck & Co has granted Sinopharm exclusive import and distribution rights to its oral Covid treatment Lagevrio (molnupiravir) in China.
Sinopharm
Chinese Vaccines Provoke Discussion
Marching to the tune of the groundswell generated by Western Covid-19 vaccines approved, distributed and administered in the US, UK and the EU in recent weeks, Chinese vaccine manufacturers have been beating the drum for their candidates in countries in Latin America and the Middle East as well as at home.
